Related Experiment Video
Updated: Jan 19, 2026

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
Published on: July 14, 2016
Tau pathology in cognitively normal older adults
Jacob Ziontz1, Murat Bilgel1, Andrea T Shafer1
1Brain Aging and Behavior Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA.
Introduction:
Tau pathology, a hallmark of Alzheimer's disease, is observed in the brains of virtually all individuals over 70 years.
Methods:
Using 18F-AV-1451 (18F-flortaucipir) positron emission tomography, we evaluated tau pathology in 54 cognitively normal participants (mean age: 77.5 years, SD: 8.9) from the Baltimore Longitudinal Study of Aging. We assessed associations between positron emission tomography signal and age, sex, race, and amyloid positivity. We investigated relationships between regional signal and retrospective rates of change in regional volumes and cognitive function adjusting for age, sex, and amyloid status.
Results:
Greater age, male sex, black race, and amyloid positivity were associated with higher 18F-AV-1451 retention in distinct brain regions. Retention in the entorhinal cortex was associated with lower entorhinal volume (β = -1.124, SE = 0.485, P = .025) and a steeper decline in memory performance (β = -0.086, SE = 0.039, P = .029).
Discussion:
Assessment of medial temporal tau pathology will provide insights into early structural brain changes associated with later cognitive impairment and Alzheimer's disease.
Related Concept Videos
05:44Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Revisionist Views of Adolescent and Adult Cognition
09:39Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
09:12Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:49In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

